The elevated levels of interleukin-13 (IL-13) and the protein periostin seen in the whole blood samples taken from patients who had uncontrolled prurigo nodularis (PN) compared with a group of ...

One potential cause of the variability in response to treatment is heterogeneity in the role of interleukin-13 expression in the clinical asthma phenotype. We hypothesized that anti–interleukin ...

Dupilumab (interleukin-4Rα; antibody binds to interleukin-4Rα, inhibiting interleukin-4 and interleukin-13 signaling in hematopoietic cells [e.g., B cells, CD4+ helper T cells, and eosinophils ...

Ebglyss is a targeted interleukin-13 inhibitor approved for the treatment of moderate-to-severe atopic dermatitis. It can be used with or without topical corticosteroids. Eli Lilly and Company ...

announced today that it has entered a Development License and Option Agreement to in-license a humanized anti-interleukin-13 (IL-13) antibody asset from AbbVie (ABBV). The asset, designated ...

Significantly greater reductions in the mean esophageal eosinophil counts occurred in patients who received the humanized anti-interleukin 13 antibody, RPC4046. SEATTLE — RPC4046, a humanized ...

Researchers discovered an unexpected link between zinc deficiency, the pro-inflammatory cytokine interleukin-13 (IL-13), and Acinetobacter baumannii lung infection and demonstrated that blocking ...

announced today that it has entered a Development License and Option Agreement to in-license a humanized anti-interleukin-13 (IL-13) antibody asset from AbbVie (NYSE: ABBV). "We are honored that ...

The researchers evaluated the correlation of interleukin-13 (IL-13) expression with AD biomarkers in lesional skin samples from 27 cases with moderate to severe AD and 38 healthy controls.